DrugDashboards

Foster and Thrive

Chlorhexidine Gluconate 4% · CHLORHEXIDINE GLUCONATE 4 g/100mL · Solution · Topical · McKesson Corporation

NDC 70677-1221-01 · 237 mL in 1 BOTTLE · NDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The price is up 23% over the past year, to $0.0367 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.02$0.04Mar 2024Sep 2026$0.0367
28 price points · per MLSource: CMS NADAC

Estimated fill cost

Estimated WAC per mLestimate
$0.038
No Texas or California filing exists for this NDC — this figure is derived, not filed.

This is an ESTIMATE derived from NADAC, not a filed or published price: pharmacies typically acquire brand drugs at roughly 2–4% below list, so list ≈ NADAC ÷ 0.97. Shown only because no state transparency filing exists for this NDC.

Medicaid spend (2024)

$10,798
317 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

5Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 5 active manufacturers+5

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for chlorhexidine gluconate (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
NDA019125
TE code
Approval date
Dec 24, 1984
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Chlorhexidine Gluconate 4% (Solution)

LabelerStrengthFirst seenLast seen
Xttrium Laboratories, Inc.CHLORHEXIDINE GLUCONATE 2 mg/100mLJul 15, 2026Sep 3, 2026
Xttrium Laboratories, Inc.CHLORHEXIDINE GLUCONATE 4 g/100mLJul 15, 2026Sep 3, 2026
Coloplast CorpCHLORHEXIDINE GLUCONATE 4 g/100mLJul 15, 2026Sep 2, 2026
HR Pharmaceuticals, Inc.CHLORHEXIDINE GLUCONATE 4 g/100mLJul 15, 2026Sep 2, 2026
McKesson CorporationCHLORHEXIDINE GLUCONATE 4 g/100mLJul 15, 2026Sep 2, 2026
Rite AidCHLORHEXIDINE GLUCONATE 4 g/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Foster and Thrive — NDC 70677-1221-01," retrieved September 3, 2026, https://drugdashboards.com/drug/70677122101.

Free to cite with attribution — see how the data is put together.